The Journal of Urology
Volume 182, Issue 2 , Pages 451-458 , August 2009

The Prognostic Predictors of Primary Ureteral Transitional Cell Carcinoma After Radical Nephroureterectomy

  • Wei-Ming Li

      Affiliations

    • Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
  • ,
  • Ching-Chia Li

      Affiliations

    • Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • Department of Urology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
  • ,
  • Hung-Lung Ke

      Affiliations

    • Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
  • ,
  • Wen-Jeng Wu

      Affiliations

    • Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • Department of Urology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Corresponding Author InformationCorrespondence and requests for reprints: Department of Urology, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Rd., Kaohsiung, 807, Taiwan (telephone: +886-7-3208212; FAX: +886-7-3211033)
  • ,
  • Chun-Nung Huang

      Affiliations

    • Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • Department of Urology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
  • ,
  • Chun-Hsiung Huang

      Affiliations

    • Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • Department of Urology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

Received 27 December 2008

References 

  1. Hall MC, Womack S, Sagalowsky AI, et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 1998;52:594
  2. Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol. 2000;164:1523
  3. Park S, Hong B, Kim CS, et al. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol. 2004;171:621
  4. Akdogan B, Dogan HS, Eskicorapci SY, et al. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol. 2006;176:48
  5. Chang CH, Yang CM, Yang AH. Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan. Cancer. 2007;109:1487
  6. Li CC, Chang TH, Wu WJ, et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol. 2008;54:1127
  7. Kang CH, Yu TJ, Hsieh HH, et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer. 2003;98:1620
  8. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137
  9. Zungri E, Chechile G, Algaba F, et al. Treatment of transitional cell carcinoma of the ureter: is the controversy justified?. Eur Urol. 1990;17:276
  10. Babaian RJ, Johnson DE. Primary carcinoma of the ureter. J Urol. 1980;123:357
  11. Anderstrom C, Johansson SL, Pettersson S, et al. Carcinoma of the ureter: a clinicopathologic study of 49 cases. J Urol. 1989;142:280
  12. Wu CF, Chang PL, Chen CS, et al. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J Urol. 2006;176:477
  13. Inamoto H, Ozaki R, Matsuzaki T, et al. Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients. Nephron. 1991;59:611
  14. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?. Lancet. 2001;357:539
  15. Oberg BP, McMenamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 2004;65:1009
  16. Saito K, Kawakami S, Ohtsuka Y, et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int. 2007;100:269
  17. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462,293 adults in Taiwan. Lancet. 2008;371:2173
  18. Cosyns JP, Jadoul M, Squifflet JP, et al. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis. 1999;33:1011
  19. Chen CH, Chiou HY, Hsueh YM, et al. Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in Taiwan. J Urol. 2009;181:547
  20. Lehmann J, Suttmann H, Kovac I, et al. Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival. Eur Urol. 2007;51:1281

 See Editorial on page 423.

PII: S0022-5347(09)00935-5

doi: 10.1016/j.juro.2009.04.026

The Journal of Urology
Volume 182, Issue 2 , Pages 451-458 , August 2009